A Terramycin, Liquamycin, Oxytetracycline CEP of the European Pharmacopoeia monograph is often referred to as a Terramycin, Liquamycin, Oxytetracycline Certificate of Suitability (COS). The purpose of a Terramycin, Liquamycin, Oxytetracycline CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Terramycin, Liquamycin, Oxytetracycline EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Terramycin, Liquamycin, Oxytetracycline to their clients by showing that a Terramycin, Liquamycin, Oxytetracycline CEP has been issued for it. The manufacturer submits a Terramycin, Liquamycin, Oxytetracycline CEP (COS) as part of the market authorization procedure, and it takes on the role of a Terramycin, Liquamycin, Oxytetracycline CEP holder for the record. Additionally, the data presented in the Terramycin, Liquamycin, Oxytetracycline CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Terramycin, Liquamycin, Oxytetracycline DMF.
A Terramycin, Liquamycin, Oxytetracycline CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Terramycin, Liquamycin, Oxytetracycline CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Terramycin, Liquamycin, Oxytetracycline suppliers with CEP (COS) on PharmaCompass.